Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 219,461 | 105,302 | 136,700 | 125,867 | 87,083 |
| Marketable Securities | 81,077 | 136,727 | 31,528 | 67,456 | 70,570 |
| Receivables | 5,298 | 48 | 1,487 | 182 | 2,466 |
| Inventories | 20,379 | 19,704 | 6,699 | 965 | N/A |
| TOTAL | $335,780 | $275,634 | $184,440 | $202,347 | $166,083 |
| Non-Current Assets | |||||
| PPE Net | 35,013 | 36,100 | 37,537 | 36,470 | 34,859 |
| Other Non-Current Assets | 13,238 | 13,359 | 7,930 | 7,701 | 7,721 |
| TOTAL | $48,251 | $49,459 | $45,467 | $44,171 | $42,580 |
| Total Assets | $384,031 | $325,093 | $229,907 | $246,518 | $208,663 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,837 | 29,744 | 21,726 | 4,793 | 10,626 |
| Accrued Expenses | 22,070 | 26,648 | 26,835 | 22,843 | 20,123 |
| TOTAL | $43,966 | $62,682 | $54,938 | $35,577 | $49,121 |
| Non-Current Liabilities | |||||
| Long Term Debt | 174,628 | 174,601 | N/A | N/A | N/A |
| Deferred Revenues | 7,836 | 6,048 | 6,116 | 7,661 | 18,095 |
| Other Non-Current Liabilities | 1,653 | 909 | 992 | 0 | 0 |
| TOTAL | $200,649 | $203,888 | $30,917 | $28,833 | $30,761 |
| Total Liabilities | $244,615 | $266,570 | $85,855 | $64,410 | $79,882 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 120,794 | 108,766 | 107,987 | 107,505 | 107,359 |
| Common Shares | 121 | 109 | 108 | 108 | 108 |
| Retained earnings | -664,067 | -598,918 | -505,016 | -461,161 | -508,796 |
| Other shareholders' equity | -1 | 12 | 5 | 7 | -9 |
| TOTAL | $139,416 | $58,523 | $144,052 | $182,108 | $128,781 |
| Total Liabilities And Equity | $384,031 | $325,093 | $229,907 | $246,518 | $208,663 |